arrow
M

Motoki Matsuura

Sapporo Medical University School of Medicine
H指数:15
被引数:2,474

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study

尼拉帕尼在经过大量预处理的同源重组缺陷型卵巢癌患者中的应用: 一项多中心2期研究的最终结果

2024-01-010
OAAI
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 study

日本铂类敏感性复发性卵巢癌患者的尼拉帕尼: 一项多中心2期研究的最终结果

2024-01-010
OAAI
Clinical Features of Patients With Second Primary Lung Cancer After Head and Neck Cancer
2024-01-011
PRE
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery
2023-07-300
PRE
EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery
2023-06-253
OAAI
Surgical outcome of ipsilateral anatomical resection for lung cancer after pulmonary lobectomy
2023-02-083
OA
Updated results of a phase 2 study of niraparib in heavily pretreated high-grade serous ovarian cancer patients in Japan
2021-07-010
PREAI
Phase 2 single-arm study on the safety of maintenance niraparib in Japanese patients with platinum-sensitive relapsed ovarian cancer

日本铂类敏感复发性卵巢癌患者维持尼拉帕尼安全性的2期单臂研究

2021-01-0110
OAAI